ImmunoPrecise Antibodies Ltd. to Post Q2 2025 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:IPA)

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA – Free Report) – Equities researchers at HC Wainwright lowered their Q2 2025 earnings estimates for shares of ImmunoPrecise Antibodies in a report issued on Tuesday, September 17th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of ($0.05) for the quarter, down from their […]

Leave a Reply

Your email address will not be published.

Previous post Ventum Cap Mkts Comments on Medexus Pharmaceuticals Inc.’s FY2025 Earnings (TSE:MDP)
Next post StockNews.com Initiates Coverage on Allied Healthcare Products (NASDAQ:AHPI)